Healthcare ❯Clinical Trials

Vaccine Efficacy

Product Pipeline Shingles Vaccine Patient Access

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women

Moderna plans to roll out the shot ahead of the 2025–26 respiratory season

Moderna to Cut $1.1 Billion in R&D Spending as Vaccine Sales Decline